Global Dental Implants Market to Spread a Predictable Worth of US$ 7,879.5 Million by 2020

According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants – Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

Some of the major drivers which help in increasing demand for dental implants are rising aging population and growing concern for oral healthcare. Rising demand for cosmetic dentistry also supports the growth of dental implants market. High cost of dental implants surgery in countries such as the U.S. and the U.K. supports the growth of medical tourism in different part of the world including Malaysia, Hungary, Costa Rica, and India. However, limited reimbursements for dental implants surgery are restraining the growth of the dental implants market. Various technological advancements in dental implants such as Computer Aided Design (CAD), 3D imaging, mini dental implants, laser dentistry, sedation dentistry, and nanotechnology have improved dental surgical procedures.

Europe is the largest market for the global dental implants due to growing concern for oral hygiene, increasing clinical adoption of dental implants therapy and technological advancements. Some of the fastest growing markets for dental implants in Europe are the U.K., France and Germany. Titanium implants is the largest material based market and is expected to grow at a CAGR of about 9.8% from 2014 to 2020.

The dental implants market in North America is expected to witness moderate growth attributed to aging population, rising awareness about oral health and technological advancement in dental implants surgery procedures. Adoption of advanced dentistry by North American people also plays important roles in driving the growth of the dental implants market. According to the American Dental Hygienists’ Association (ADHA), approximately 75% of American adults were suffering from various forms of gum diseases in 2008. However, Asia Pacific is the fastest growing dental implants market. Growing concern about oral health and medical tourism are some factors driving the growth of the dental implant in the Asia Pacific market.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2821

Institut Straumann AG is one of the leading players in the dental implants market. Other major players of dental implants market include Nobel Biocare, DENTSPLY International Inc. and Zimmer dental Inc., 3M Company and Neoss International.

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/2821

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Advertisements

Global Clinical Trial Management System Market will hit at a CAGR of 14% by 2019

According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

 Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with hospital information system (HIS) provides more accurate and time saving documentation is also driving growth for the CTMS market. Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. Due to regulatory and legal considerations and the clinical trial market has shifted from North America to developing countries such as India and China. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry.

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. Due to governmental support and funding for biomedical sciences, Germany has become a preferred location for clinical trials.

However, Asia is the fastest growing region in the clinical trial management system market.. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3017

Some of the major players in the CTMS market are Oracle Corporation, Bio-Optronics, MedNet Solutions, PAREXEL International Corporation, Medidata Solutions and BioClinica

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/3017

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Extracorporeal Blood Treatment Market : Key Players, Growth and Analysis by 2017 – 2025

Blood purification has always been viewed as a branch of medicine which is extremely crucial and complicated. In 1950’s after the breakthrough of clinical dialysis different manufacturers invested in latest technologies and started as a supplier of extracorporeal blood treatment. The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood. By the end of 1960’s, a company named B Braun started to manufacture its own dialysis machine. As the number of manufacturers increased, the use of these dialysis machines brought upon patient safety issues. In the 1980’s extracorporeal blood treatment systems became significantly user-friendly as there was more and more digitalization in these systems.

A Sample of this Report is Available Upon Request @ www.persistencemarketresearch.com/samples/15685

Extracorporeal Blood Treatment Market: Drivers and Restraints

The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases. The demand for kidney dialysis has increased as the prevalence of chronic conditions such as hypertension, heart diseases and diabetes are on a rise along with the elderly population. International statistics has shown that as compared to other advanced countries such as Japan, U.S. has a higher rate of dialysis utilization. In 1960, the first dialysis center was started and the establishment of Medicare’s End Stage Renal Disease Program ensured the coverage of expensive dialysis treatment. From its establishment in 1973, around 400,000 people have received dialysis under the Medicare’s End Stage Renal Disease Program.

Extracorporeal Blood Treatment Market: Overview

Extracorporeal blood treatment is a purification process that takes place outside the body. The blood passes through the membrane, filters the waste or molecules within the extracorporeal region and returning to normal state. Purified blood is then returned back to the patient’s body suffering from kidney injury.

The growth of the dialysis facilities in the U.S. has increased by 6% annually over the past five years. There has been an increase in the population of U.S. diagnosed with end-stage renal disease.

According to the data provided by the U.S. Renal Data System, in 2013 the number of patient who underwent dialysis were 468,000. The 47 fold increase in the dialysis procedure in the past 40 years is driven by the rise in diabetes and other chronic conditions.

Extracorporeal Blood Treatment Market: Region-wise Outlook

In terms of geography, extracorporeal blood treatment market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America region dominated the extracorporeal blood treatment market owing to the presence of undisputed market players, the presence of strong research developments and presence of insurance coverage. For instance, Baxter presented their study on the role of extracorporeal blood purification in the removal of molecules which leads to inflammation. Economically developing region such as Asia Pacific is expected to be the fastest growing with the presence of huge population base and also an increase in the number of patient undergoing dialysis.

To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/15685

Extracorporeal Blood Treatment Market: Key Market Participants

Some of the extracorporeal blood treatment market participants are Fresenius Medical Care N.A., DaVita Kidney Care, U.S. Renal Care, Dialysis Clinic Inc., American Renal Associates, Satellite Healthcare, Atlantic Dialysis Management, Northwest Kidney Centers, Centers for Dialyssis Care and Rogosin Institute.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Global Veterinary Teleradiology Market to Surge at a Robust Pace in Terms of Revenue Over 2017 – 2025

Veterinary teleradiology is the practice of medical images interpretation and analysis by a radiologist who is not present at the site where the images were generated. This market is utilized by hospitals, pet clinics, and veterinary radiology centers. Teleradiology enables radiologists to use advanced teleradiology solutions in order to improve patients care and treatment without any delay in the treatment process. The concept of teleradiology arose due to dearth of radiologists, as the specialized group of people is generally located in metropolitan areas. Teleradiology markets enable trained specialists to provide their interpretation and guidance 24/7 across the globe.

A Sample of this Report is Available Upon Request @  http://www.persistencemarketresearch.com/samples/15628

The primary factor fuelling demand for teleradiology market is increasing domestic, livestock and companion animal industry, rising animal disease and accidental cases, growing number of veterinary practitioners and the income levels. In addition rising innovations in teleradiology services, which offer rapid and accurate results to customers.  However, a primary factor hampering growth of the teleradiology market is the risk of data security, high cost of technology, dearth of trained radiologists and technicians and transformation access to remote areas.

High cost of services, image transmission issues, low awareness in emerging economies are going to be a major challenge for veterinary teleradiology services market. Manufacturers are expected to invest more on the product technology for quick transformation of data which include various parameters of information and technology. Ongoing trends for teleradiology services are driving the whole market coupled with the latest IT infrastructure which also include artificial intelligence and algorithms, cloud with low maintenance and image backup storage.

The global market for veterinary teleradiology is segmented on basis of product type, construction material, end user and geography:

Segmentation by Service Type

Emergency Care, Day Time Coverage, Second Opinion, Sub-specialty Reading

Segmentation by Modality Material

X-ray, Computerized Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Ultrasound Scans, Nuclear Scan

Segmentation by End User

Hospitals, Pet Clinics, Veterinary Radiology Centers

Based on services type, the market has been segmented into emergency care, day time coverage, subspecialty reading, and second opinion. Day care and emergency care dominates the global veterinary teleradiology services market and is expected to do so throughout the forecast period. This service type segment is anticipated to expand with the fastest CAGR over the forecast period.

Based on modality type, the market is segmented into X-Ray Scans, CT Scans, MRI Scans, Ultrasound Scans, Nuclear Scan, and Others. In terms of revenue share, CT scans dominated the veterinary teleradiology Market owing to increase in CT scans in the region is projected to do so throughout the forecast period. However, MRI scans are projected to grow with high CAGR than other modalities over the forecast period.

Based on end user, the global veterinary teleradiology market has been segmented into hospitals, pet clinics and veterinary radiology centers. Hospitals are expected to contribute highest share in the global veterinary teleradiology market over the forecast period.

On the basis of regional presence, global veterinary teleradiology market is segmented into five key regions namely North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market due to large number of pet adoption, increasing disease and accidental cases in pet animals, and growing expenditure on animal healthcare, while Europe is expected to hold second largest market share in the global market. Market in Asia-Pacific region is expected to witness significant growth rate over the forecast period owing to growing trend of pet adoption and increasing focus on teleradiology services.

Some of the players operating in global veterinary teleradiology market are VetCT, Veterinary Imaging Consultations, Inc., Lynks Group, Animal Imaging Consultants, Vet-Rad LTD, Veterinary Medical Centers, and PetRays among others.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/15628

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

 

Global Immunoassay Systems Market to Register Steady Growth During 2017 – 2025

Immunoassay has become essential laboratory technique that can be used to measure concentration of different analytes. Immunoassay systems are thus essentially adopted by virtually all the diagnostic laboratories, academic and research institutes, hospital diagnostic centers and other potential end users. Introduction of multiplex immunoassays has further expanded the applications of immunoassay systems in different industries such as pharmaceutical companies, biotechnology and life science industries, food and beverage industries, environment control measurements etc. Modern immunoassays employ labeling techniques such as enzyme labeled, radiolabelled, chromophore labelled, fluorescence labelled etc. and immunoassay systems are used to detect these labelled analytes qualitatively or quantitatively. Some of the established brands in global immunoassay systems include ADVIA (Siemens), UniCel DxI (Beckman Coulter), IDS-iSYS (Immunodiagnostic Systems Inc.), LUMINEX (Luminex Corporation), Cobas Analyzer (Roche) etc. among others. Companies offering multiplex immunoassay systems are expanding their efficiency of multiplexing which is expected to boost the demand for these devices over time. These established brands are benefited with customer loyalty and high cost of instrument switching.

A Sample of this Report is Available Upon Request @  http://www.persistencemarketresearch.com/samples/15613

The global market for immunoassay systems is expected to be driven by adoption of immunoassay systems by academic and research institutes in U.S. and Europe. Moreover, continuous increase in R&D expenditures and increasing research grants and government funding to research laboratories would further increase the demand for immunoassay systems. Growing automation in diagnostic laboratories would demand the more use of automated immunoassay systems in order to fulfil the need for performing more in less cost. Recent advancements in multiples immunoassay and expansion of its applications in veterinary diagnostics and food contamination testing would expand the install base of immunoassay systems in these industries. However, stringent regulatory requirements and frequent recalls of immunoassay systems is the major factor limiting the growth of global immunoassay systems market. For instance, recently in July 2016, FDA announced recall of ADVIA Centaur XPT system due to defective results generated by system software.

In recent there has not been much innovation in the immunoassay systems technology. However, manufacturers of immunoassay systems are cross collaborating with developers of immunoassay kits and reagents. Moreover, manufacturers who provide immunoassay kits and reagents for their own system are focusing to launch new or improved immunoassay kits in order to ensure the continuation of services and customer retention for already installed immunoassay systems.

The global market for immunoassay systems is segmented on basis of product type, technology, end user and geography:

Segmentation by Product Type

Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Nephelometric Immunoassay Systems, Radio Immunoassay Systems, Others

Segmentation by Technology

Single Plex Immunoassay Systems, Multiplex Immunoassay Systems

Segmentation by End User

Diagnostic Centers, Pharmaceutical Companies, Academic and Research Institutes, Government Agencies, Others

Based on product type, fluorescence and chemluminescence immunoassay systems collectively contributed highest share in global immunoassay systems market so far. Based on end user, global immunoassay systems market has been segmented into diagnostic centers, pharmaceutical companies, academic and research institutes, government agencies and others. Diagnostic laboratories and pharmaceutical companies contribute highest share in global immunoassay systems maret.

Regionally, global immunoassay systems market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America clearly dominates the global market for immunoassay systems due to huge install base and growing adoption of these systems in academics and research institutes. Europe is expected to be the second largest market for immunoassay systems owing to consolidation of immunoassay system providers and manufacturers in the region in recent years. Asia pacific immunoassay systems market is expected to witness impressive growth rate over the forecast period of 2017–2025, primarily due to high demand for immunoassay systems in Japan and Australia.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/15613

Some of the players identified in global immunoassay systems market include Siemens Healthcare Private Limited, Beckman Coulter, Inc. (Danaher Corporation), Thermo Fisher Scientific Inc., Promega Corporation, Immunodiagnostic Systems Inc., Bio Rad Laboratories Inc., EMD Millipore (Merck KGaA), F. Hoffmann-La Roche Ltd. etc. among others. All the companies operating in immunoassay systems market also provide immunoassay kits and reagents specific to their systems. Major players are trying to maximize their install base for immunoassay systems on the basis of long term contracts with the end customer to purchase reagents and kits specific to their immunoassay system.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Oral Antidiabetic (OAD) Treatment Market to Significant Growth Foreseen by 2025

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. The world is moving toward the diabetic’s world according to the International Diabetes Federation 415 million people are diabetes in 2015. This directly affect the market to come up with new innovations for diagnosis and treatment. The main cause of diabetes is the unstable lifestyle habits of the population which include physical inactivity, unhealthy diet, obesity, and smoking and in some cases the family history is also the strong risk of the diabetes. Various treatment method are present in the market injection, oral and others.

A Sample of this Report is Available Upon Request @ www.persistencemarketresearch.com/samples/15562

Oral Antidiabetic (OAD) Treatment Market : Drivers & Restraints
Oral antidiabetic treatment is the most widely used method in the market, many players are coming with various product in the market. For instance, in August 2015, Glenmark Pharmaceuticals Limited has lunched generic Teneligliptin which was a third-generation oral anti-diabetic drug. The awareness program is also going by various private and government organization. The research organization are also working in antidiabetic sector to come up with various generation of diagnosis and treatment. The higher costing of the drugs is the hindrance of the market.

Oral Antidiabetic (OAD) Treatment Market: Segmentation
Oral Antidiabetic (OAD) Treatment Market segmentation based on:

Based on Drug Type
Sulphonylureas, Biguanides, Intestinal α-glucosidase inhibitors, Others

Based on End User
Hospital, Pharmacy Store, Drug Store, Diabetics Treatment Centres, Others

Based on Geography
North America, Europe, Latin America, Asia-Pacific, Middle East and Africa

Oral antidiabetic market is a growing market over the forecast period, many step are taken by the government in respect with funding and the other support for research. Various government organization has been formed in recent year and actively working on it as IDF or Diabetics Australia and many others. Many research is going on for developing low cost drugs for the treatment as diabetes is the major problem in coming years, according to the IDF 1 of the 11 adults have diabetes and 1 in 2 adults are having diabetes which is undiagnosed. The automatically fuel the market to come up with major innovations.

As a geography conditions the Oral Antidiabetic (OAD) Treatment Market is segmented into: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.

To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/15562

Some players in Oral Antidiabetic (OAD) Treatment Market are Eli Lilly and Company, AstraZeneca, Glenmark Pharmaceuticals Limited Novo Nordisk A/S, MSD & Co., Inc., Mannkind Corporation and Sanofi.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

 

Biomonitoring and Bioburden Testing Market to Witness a Pronounce Growth During 2017 – 2025

Measuring of toxic compounds, elements and other harmful agents in a biological sample, the biomonitoring can provide the information on the environment and the form of information will be the quantitative, so that the absolute value can get for the treatment process. Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the number of bacteria present on the surface, the surface is not show sterilized. The present of bacteria on the surface can affect the industry like pharmaceutical and other industry which is directly related to the human begins. Various regulation has been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the U.S the Title 21 is the code of federal regulation that cover the drugs and food for FDA. Many other organization are also having the code and standard parameter for monitoring.

A Sample of this Report is Available Upon Request @ www.persistencemarketresearch.com/samples/15547

Biomonitoring and Bioburden Testing Market: Drivers & Restraints

Biomonitoring and Bioburden testing market is a growing market, as there is growth in the pharmaceutical, biotechnology, medical devices, food industry and other industry every year and the guideline of the respective association are very strike for the industries. The product produce by this industry are directly or indirectly taken or affect the human. As the Centers for Disease Control and Prevention (U.S. Department of Health & Human Services) conduct by NBP (National Biomonitoring Program) which measure approx. 300 or more chemical and nutritional indicator in people. The costing and the approval process in various countries are the hindrance for this market.

Biomonitoring and Bioburden Testing Market: Segmentation
Biomonitoring and Bioburden Testing Market segmentation based on:

By Product type
Culture Media and Reagents Kit, Instruments, PCR (Polymerase Chain Reaction), Automated Microbial Identification systems, Microscope, Others

By Application

Medical devices testing, Monitoring of manufacturing process, Environmental monitoring

By End User
Pharmaceutical and Biotechnology Companies, Microbial testing laboratories, Manufacturing unit of food & beverage, agricultural products, medical devices and others

Based on Geography
North America, Europe, Latin America, Asia-Pacific, Middle East and Africa

Biomonitoring and Bioburden Testing is a potential market which is directly linked with the human health and the ecosystem. The bioburden testing is required for the drug investigation and provide the quantity of viable microorganisms in or on system. For instance, one of the players Merck KGaA., has the product for testing of bioburden name as EZ Fluo™ Rapid Detection, Ready-to-Use Culture Media for Bioburden Testing, and others.

As a geography conditions the Biomonitoring and Bioburden Testing Market is segmented into: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America have the major number of industries like pharmaceutical, food and others industries which directly indicate the market. Asia Pacific is a growing market as in terms of industries and awareness is also increasing for the testing and getting the approvals.

To view TOC of this report is available upon request @
www.persistencemarketresearch.com/toc/15547

Some players in Biomonitoring and Bioburden Testing Market are Merck KGaA. , STERIS Laboratories, Charles River Laboratories International, Inc., Lumex Instruments, Pacific BioLabs, Sigma-Aldrich Co., WuXi AppTec, Dynatec Labs ,Merck & Co., Inc., and Nelson Laboratories, LLC

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.